☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Ironwood Pharmaceuticals
Ironwood Pharmaceuticals Reports Results for Apraglutide in P-III Trial for the Treatment of Short Bowel Syndrome with Intestinal...
March 1, 2024
Ironwood Pharmaceuticals’ Linzess (linaclotide) Receives the US FDA’s Approval for the Treatment of Functional Constipation in Ped...
June 13, 2023
Insights+: Key Deals of J.P. Morgan Healthcare Conference 2020
February 7, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.